EA202092760A1 - Композиция афродизиака и терапия мужской сексуальной дисфункции - Google Patents

Композиция афродизиака и терапия мужской сексуальной дисфункции

Info

Publication number
EA202092760A1
EA202092760A1 EA202092760A EA202092760A EA202092760A1 EA 202092760 A1 EA202092760 A1 EA 202092760A1 EA 202092760 A EA202092760 A EA 202092760A EA 202092760 A EA202092760 A EA 202092760A EA 202092760 A1 EA202092760 A1 EA 202092760A1
Authority
EA
Eurasian Patent Office
Prior art keywords
weight
extract
composition
sexual dysfunction
male sexual
Prior art date
Application number
EA202092760A
Other languages
English (en)
Russian (ru)
Inventor
Мухаммед Маджид
Кальянам Нагабхушанам
Саранг Бани
Анджали Пандей
Original Assignee
Сами Лабс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сами Лабс Лимитед filed Critical Сами Лабс Лимитед
Publication of EA202092760A1 publication Critical patent/EA202092760A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA202092760A 2019-02-22 2019-04-17 Композиция афродизиака и терапия мужской сексуальной дисфункции EA202092760A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201941006993A IN201941006993A (enExample) 2019-02-22 2019-02-22
PCT/US2019/027783 WO2020171833A1 (en) 2019-02-22 2019-04-17 Aphrodisiac composition and management of male sexual dysfunction

Publications (1)

Publication Number Publication Date
EA202092760A1 true EA202092760A1 (ru) 2021-12-21

Family

ID=72142598

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092760A EA202092760A1 (ru) 2019-02-22 2019-04-17 Композиция афродизиака и терапия мужской сексуальной дисфункции

Country Status (10)

Country Link
US (1) US10864242B2 (enExample)
EP (1) EP3927360A4 (enExample)
JP (1) JP7717461B2 (enExample)
KR (1) KR102571381B1 (enExample)
AU (1) AU2019430124B2 (enExample)
EA (1) EA202092760A1 (enExample)
IN (1) IN201941006993A (enExample)
MX (1) MX2020013340A (enExample)
WO (1) WO2020171833A1 (enExample)
ZA (1) ZA202007819B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN201941006993A (enExample) * 2019-02-22 2019-03-01

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010041187A1 (en) * 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
EP1208845A4 (en) * 1999-05-10 2004-06-02 Nippon Shinyaku Co Ltd COMPOSITIONS FOR TREATING HYPOFERTILITY
KR100517637B1 (ko) 2001-12-21 2005-09-28 씨제이 주식회사 섬수 정제 엑스 및 인삼 정제 엑스를 함께 함유하면서다른 정유 생약 성분은 함유하지 않는 조루증의 예방 및치료용 조성물
ITMI20031428A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi e loro uso per il trattamento di disfunzioni sessuali
JP5345778B2 (ja) * 2004-04-27 2013-11-20 ラジェンドラン，ラムズワーミー 肥満、肥満に関連する障害、および他の障害の治療／管理におけるプレグナン配糖体の使用
US20060269623A1 (en) 2005-05-31 2006-11-30 Pierre Swaab Herbal composition and method of use for promoting erections and treating erectile dysfunction in men
US20110064720A1 (en) * 2009-09-16 2011-03-17 Daniel Moses Amato Dietary Supplement Compositions and Methods of Making and Using the Same
CN108712907A (zh) * 2016-03-11 2018-10-26 哈摩尼克制药公司 包含天然提取物的舌下组合物及其用途
WO2018033892A1 (en) * 2016-08-19 2018-02-22 Aurea Biolabs Private Limited A formulation for improving physical endurance in athletes and a method for preparing the samea formulation for improving physical endurance in athletes and a method for preparing the same
WO2018220232A1 (en) 2017-06-02 2018-12-06 Universite De Versailles-St Quentin En Yvelines Pharmaceutical combination product comprising botulinum toxin for the treatment of erectile dysfunction
IN201941006993A (enExample) * 2019-02-22 2019-03-01

Also Published As

Publication number Publication date
CA3103127A1 (en) 2020-08-27
JP2022524665A (ja) 2022-05-10
MX2020013340A (es) 2021-02-02
IN201941006993A (enExample) 2019-03-01
BR112020025686A2 (pt) 2021-08-31
US10864242B2 (en) 2020-12-15
WO2020171833A1 (en) 2020-08-27
US20200268822A1 (en) 2020-08-27
EP3927360A1 (en) 2021-12-29
KR20210024615A (ko) 2021-03-05
AU2019430124B2 (en) 2023-10-19
JP7717461B2 (ja) 2025-08-04
AU2019430124A1 (en) 2021-07-22
EP3927360A4 (en) 2022-11-16
ZA202007819B (en) 2022-12-21
KR102571381B1 (ko) 2023-08-28

Similar Documents

Publication Publication Date Title
ZA202204929B (en) Rimegepant for cgrp related disorders
EA202092490A1 (ru) Модуляторы метилмодифицирующих ферментов, композиции и их применения
CO2019013707A2 (es) Polinucleótidos de aadc para el tratamiento de la enfermedad de parkinson
EA201992607A1 (ru) Твердые формы берберина урсодезоксихолата, их композиции и способы
JOP20190147A1 (ar) تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
MX2016010213A (es) Formulaciones farmaceuticas novedosas.
CO2019009722A2 (es) Dendrímeros terapéuticos
CL2021000030A1 (es) Uso de estimuladores de la sgc para el tratamiento de trastornos mitocondriales
MX391392B (es) ANILLOS 5-5 FUSIONADOS COMO INHIBIDORES C5a.
NZ776554A (en) Capsule formulations
MX2023000187A (es) Dosificacion de vibegron para el tratamiento de vejiga sobreactiva.
ZA202000028B (en) Use of vibegron to treat overactive bladder
PH12021550671A1 (en) Prodrugs of cgrp antagonists
EA202190308A1 (ru) Применение пролекарств рилузола для лечения болезни альцгеймера
BRPI0407693A (pt) uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos
EA202092760A1 (ru) Композиция афродизиака и терапия мужской сексуальной дисфункции
BR112018073419A2 (pt) combinação, uso da combinação, método para o tratamento, composto, método para o tratamento de doença de alzheimer e composição farmacêutica
EA202092763A1 (ru) Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных
MX386521B (es) Composiciones farmaceuticas que contienen un relajante muscular y un antiinflamatorio no esteroideo (aine).
BR112018073396A2 (pt) combinação de antagonistas, uso de uma combinação, método para o tratamento de desordens cognitivas, composto, método para o tratamento de doença de alzheimer e composição farmacêutica
SA520411067B1 (ar) تركيبات صلبة فموية من بيتا هستين ممتدة الإطلاق غير نابضة
MX2021007324A (es) Terapia oral con acido 6,8-bis-benciltio-octanoico.
PL425832A1 (pl) Genisteina oraz jej kompozycja do zastosowania w leczeniu choroby Alzheimera
EA202091127A1 (ru) Фармацевтические композиции, включающие сафинамид
TR201719926A2 (tr) Farmasöti̇k olarak kabul edi̇lebi̇li̇r li̇tyum tuzlari ve c vi̇tami̇ni̇ i̇çeren farmasöti̇k bi̇leşi̇mler